Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-078287
Filing Date
2022-03-17
Accepted
2022-03-17 16:02:50
Documents
75
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d274434d10k.htm   iXBRL 10-K 1787004
2 EX-21.1 d274434dex211.htm EX-21.1 1990
3 EX-23.1 d274434dex231.htm EX-23.1 3360
4 EX-31.1 d274434dex311.htm EX-31.1 10404
5 EX-31.2 d274434dex312.htm EX-31.2 10414
6 EX-32.1 d274434dex321.htm EX-32.1 5052
12 GRAPHIC g274434g73a92.jpg GRAPHIC 27946
  Complete submission text file 0001193125-22-078287.txt   7456499

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cbay-20211231.xsd EX-101.SCH 55958
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20211231_cal.xml EX-101.CAL 42707
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20211231_def.xml EX-101.DEF 250578
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20211231_lab.xml EX-101.LAB 465339
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20211231_pre.xml EX-101.PRE 367529
69 EXTRACTED XBRL INSTANCE DOCUMENT d274434d10k_htm.xml XML 1183468
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36500 | Film No.: 22748430
SIC: 2834 Pharmaceutical Preparations